Per a study published in April in Genome Medicine , people who carried certain mutations in their PAM (peptidyl-gylcine alpha-amidating monooxygenase) genes, which are key for processing hormones, were less likely to respond to GLP-1 drugs
ABD Gda ve la Dairesi (FDA), bu tr risklere dikkat ekerek rn etiketlerinde gncellemeler yaplmasn istemitir (3)
3df and Supplementary Data 4)
European Journal of Pharmacology , 570(13), 212221
A review of 63 trials involving more than 9,000 people, published in the British Medical Journal and cited by Global News , found that patients on weightloss drugs regained weight at an average of 0.4 kilograms per month after stopping treatment
I.CuzicS.BrajsaK.MildnerB.BokulicA.SitumK.et al (2007)